Biotechnology
Technology
Health

Bio-Techne

$197.79
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.07 (-0.04%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Bio-Techne and other stocks, options, ETFs, and crypto commission-free!

About

Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the following segments: Biotechnology, Protein Platforms, Diagnostics, and Corporate. Read More The Biotechnology segment supplies specialized proteins, such as cytokines and growth factors, immunoassays, antibodies and related reagents, as well as in situ hybridization, media and other cell culture products and reagents to the biotechnology research community. The Protein Platforms segment develops, manufactures, and sells tools to simplify protein analysis. The Diagnostics segment includes blood chemistry and blood gas quality controls, hematology instrument controls, diagnostic immunoassays, and other bulk and custom reagents for the in vitro diagnostic market worldwide. The company was founded on 1976 and is headquartered in Minneapolis, MN.

Employees
1,943
Headquarters
Minneapolis, Minnesota
Founded
1976
Market Cap
7.48B
Price-Earnings Ratio
63.38
Dividend Yield
0.87
Average Volume
210.60K
High Today
$201.22
Low Today
$197.38
Open Price
$199.25
Volume
44.73K
52 Week High
$207.84
52 Week Low
$132.75

Collections

Biotechnology
Technology
Health
Medical
Media
Gas
Oil and Gas
Fossil Fuel

News

Yahoo FinanceMay 21

Bio-Techne To Present At The Jefferies 2019 Global Healthcare Conference

MINNEAPOLIS, May 21, 2019 /PRNewswire/ -- Bio-Techne Corporation (TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Jefferies 2019 Global Healthcare Conference on Wednesday, June 5th, 2019, at 9:30 a.m. EDT. The conference will be held at the Grand Hyatt Hotel in New York City.

14
Yahoo FinanceMay 14

Does Bio-Techne Corporation's Past Performance Indicate A Stronger Future?

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Measuring Bio-Techne Corporation's (NASDAQ:TECH) track record of past performance is a valuable exercise for investors. It allows us to understand whether or not the company has met or exceed expectations, which is an insightful signal for future performance. Today I will assess TECH's recent performance announced on 31 March 2019 and compare these figures to its historical trend and ...

8
NasdaqMay 8

Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for May 09, 2019

Bio-Techne Corp ( TECH ) will begin trading ex-dividend on May 09, 2019. A cash dividend payment of $0.32 per share is scheduled to be paid on May 24, 2019. Shareholders who purchased TECH prior to the ex-dividend date are eligible for the cash dividend payment.

15

Earnings

$0.88
$1.03
$1.19
$1.34
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
โ€”
Actual
Expected Aug 6, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.